Sarcoidosis pediátrica. Revisión.
Keywords:
SARCOIDIOSISAbstract
Se realiza una revisión actualizada sobre las peculiaridades clínicas, radiológicas y neuropatológicas de la Sarcoidosis. Esta enfermedad tiene un amplio espectro clínico cuyos síntomas pueden ser inespecíficos o tener afectación orgánica múltiple. El eritema nudoso asociado a erupciones maculopapulosas, linfoadenopatías, cuadros obstructivos con progresión hacia la insuficiencia respiratoria y la afectación glandular son las alteraciones comunmente observadas en el niño. La fibrosis progresiva del parénquima, la atelectasia distal, la arteritis granulomatosa de grandes vasos pulmonares y el derrame unilateral, constituyen las formas de presentación habitual de la Sarcoidosis pulmonar, identificables radiologicamente mediante gammagrafia con galio y tomografía axial computarizada. El diagnóstico exige la demostración de las lesiones granulomatosas no caseificantes en un estudio histológico. La confirmación diagnóstica permite evaluar periódicamente los casos así como prevenir las posibles complicaciones.Downloads
Download data is not yet available.
References
1. Behrman Richard E, Kliegman Robert M, Arvin Ann M, Nelson Waldo E. Sarcoidosis. En: Behrman Richard E, Kliegman Robert M, Arvin Ann M, Nelson Waldo E. Tratado de Pediatría. La Habana: Editorial de Ciencias Médicas; 1998. p. 2485 – 86.
2. Serra–Baldrich E, Tribó MI. Sarcoidosis (II). Inmunopatogenesis o criterios de actividad. Conclusión. Act Dermatol. 2001; 12: 999-1010.
3. Milman N, Hoffman AL, Byg KE. Sarcoidosis in Children. Epidemiology in Danes, Clinical featuns, diagnosis, treatment and prognosis. Pediatr. 1998; 87: 871 – 8.
4. Romero González J, Martínez García S, Vera Casaño A. Sarcoidosis en la infancia. (Monografia en Internet)Servicio de dermatología. Complejo Hospitalario Carlos Haya. Málaga. España, 2005. (citado 20 Feb 2007) Disponible en: http://www.doyma.es
5. Clark SC. Sarcoidosis in Children. Pediatr Dermatol. 1997; 4: 291–9.
6. Braun Falco O, Plewig G, Wollf HH, Burgdorf WHc. Dermatology. 2nd ed. Berlin: Springer; 2000.
7. Seo SK, Yeum JS, Suh JC, Na GY. Lichenoid Sarcoidosis in 3 year–old girl. Pediatr Dermatol. 2001; 18: 384–7.
8. Hetherengton S. Sarcoidosis in Children. Comp Ther. 1982; 8: 63-8.
9. Katoh N, Mihara H, Yasumo H. Cutaneous Sarcoidosis successfully treated with tropical tacolimus. Br J Dermatol. 2002; 147: 154–6.
10. English JC, Puvisha JP, Kenneth EG. Sarcoidosis. J Am Acad Dermatol. 2001; 44: 725–43.
11. Fink CW, Sirnaz R. Early onset sarcoidosis: not a benign disease. J Rheurnatol. 1997; 24: 174–7.
12. Mar Baughman RP, Lower EE. Methotrexate is steroid sparing in acute Sarcoidosis, results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Mar;17(1):60-6.
13. Morrel F, Levy G, Orriols R, Ferrer J, Degracia I, Sampol G. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest 2002; 121: 139–44.
14. Du Bois RM, Greenhalgh PM, Soulhcott AM, Johson NM, Harris TA. Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study. Eur Resp J. 1999; 13: 1345–50.
15. WinterBauer RH. Lamumert J, Selland M, Wu R. Corley D, Sprint Nneyer SC. Bronchoalveolar Lavage. Population in the diagnosis oft Sarcoidosis. Chest 1999; 104: 351 – 61.
2. Serra–Baldrich E, Tribó MI. Sarcoidosis (II). Inmunopatogenesis o criterios de actividad. Conclusión. Act Dermatol. 2001; 12: 999-1010.
3. Milman N, Hoffman AL, Byg KE. Sarcoidosis in Children. Epidemiology in Danes, Clinical featuns, diagnosis, treatment and prognosis. Pediatr. 1998; 87: 871 – 8.
4. Romero González J, Martínez García S, Vera Casaño A. Sarcoidosis en la infancia. (Monografia en Internet)Servicio de dermatología. Complejo Hospitalario Carlos Haya. Málaga. España, 2005. (citado 20 Feb 2007) Disponible en: http://www.doyma.es
5. Clark SC. Sarcoidosis in Children. Pediatr Dermatol. 1997; 4: 291–9.
6. Braun Falco O, Plewig G, Wollf HH, Burgdorf WHc. Dermatology. 2nd ed. Berlin: Springer; 2000.
7. Seo SK, Yeum JS, Suh JC, Na GY. Lichenoid Sarcoidosis in 3 year–old girl. Pediatr Dermatol. 2001; 18: 384–7.
8. Hetherengton S. Sarcoidosis in Children. Comp Ther. 1982; 8: 63-8.
9. Katoh N, Mihara H, Yasumo H. Cutaneous Sarcoidosis successfully treated with tropical tacolimus. Br J Dermatol. 2002; 147: 154–6.
10. English JC, Puvisha JP, Kenneth EG. Sarcoidosis. J Am Acad Dermatol. 2001; 44: 725–43.
11. Fink CW, Sirnaz R. Early onset sarcoidosis: not a benign disease. J Rheurnatol. 1997; 24: 174–7.
12. Mar Baughman RP, Lower EE. Methotrexate is steroid sparing in acute Sarcoidosis, results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Mar;17(1):60-6.
13. Morrel F, Levy G, Orriols R, Ferrer J, Degracia I, Sampol G. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest 2002; 121: 139–44.
14. Du Bois RM, Greenhalgh PM, Soulhcott AM, Johson NM, Harris TA. Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study. Eur Resp J. 1999; 13: 1345–50.
15. WinterBauer RH. Lamumert J, Selland M, Wu R. Corley D, Sprint Nneyer SC. Bronchoalveolar Lavage. Population in the diagnosis oft Sarcoidosis. Chest 1999; 104: 351 – 61.
Downloads
How to Cite
1.
Díaz Colina JA. Sarcoidosis pediátrica. Revisión. Mediciego [Internet]. 2018 Sep. 14 [cited 2024 Nov. 27];13(1). Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/2817
Issue
Section
Review article
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
